Profile picture

Doctor Arancha Diaz Exposito

Virgin of Victory University Hospital, Malaga (Spain)
Membership: HFA Member
Follow
Logo ESC

Contributor content

Prevalence of ICD therapies in primary prevention vs secondary prevention in a sample of patients diagnosed with arrhythmogenic cardiomyopathy
Presentation
Prevalence of ICD therapies in primary prevention vs secondary prevention in a sample of patients diagnosed with arrhythmogenic cardiomyopathy
A new phenotypic presentation of the p.Gly1743Arg variant in SCN5A classically associated with Brugada syndrome.
Presentation
A new phenotypic presentation of the p.Gly1743Arg variant in SCN5A classically associated with Brugada syndrome.
Phenotypic manifestation based on genetics and prevalence of secondary mutations in a sample of patients diagnosed with arrhythmogenic cardiomyopathy
Presentation
Phenotypic manifestation based on genetics and prevalence of secondary mutations in a sample of patients diagnosed with arrhythmogenic cardiomyopathy
What the heart hides. Necrotising myopathy due to SRP antibodies with associated cardiac involvement in the context of mucinous adenocarcinoma of the lung.
Presentation
What the heart hides. Necrotising myopathy due to SRP antibodies with associated cardiac involvement in the context of mucinous adenocarcinoma of the lung.
ICD implantation in primary prevention. Beyond left ventricular ejection fraction.
Presentation
ICD implantation in primary prevention. Beyond left ventricular ejection fraction.
Incidence and progression of left ventricular involvement in patients with arrythmogenic cardiomyopathy
Presentation
Incidence and progression of left ventricular involvement in patients with arrythmogenic cardiomyopathy
Hypertrophic cardiomyopathy and pulmonary hypertension. A lethal combination
Presentation
Hypertrophic cardiomyopathy and pulmonary hypertension. A lethal combination
New clues to the diagnosis of dynamic obstructive gradiente in hypertrophic cardiomyopathy. The power of ergoespirometry
Presentation
New clues to the diagnosis of dynamic obstructive gradiente in hypertrophic cardiomyopathy. The power of ergoespirometry
A new possibly pathogenic mutation in the ACTA 1 gene. Beyond skeletal muscle involvement
Presentation
A new possibly pathogenic mutation in the ACTA 1 gene. Beyond skeletal muscle involvement
Evolution of patients with advanced heart failure with ambulatory intermitent infusions of long-term Levosimendan
Presentation
Evolution of patients with advanced heart failure with ambulatory intermitent infusions of long-term Levosimendan

ESC 365 is supported by